J. Joseph Bergera - 29 Feb 2024 Form 4 Insider Report for ITERIS, INC.

Role
President and CEO, Director
Signature
/s/ Donald R. Reynolds, Attorney-in-Fact for Joseph Bergera
Issuer symbol
N/A
Transactions as of
29 Feb 2024
Net transactions value
-$189,095
Form type
4
Filing time
04 Mar 2024, 18:05:17 UTC
Previous filing
20 Nov 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITI Common Stock Options Exercise $33,320 +14,000 +7.8% $2.38 193,138 29 Feb 2024 Direct
transaction ITI Common Stock Sale $55,564 -10,714 -5.5% $5.19 182,424 29 Feb 2024 Direct F1, F2
transaction ITI Common Stock Options Exercise $44,030 +18,500 +10% $2.38 200,924 01 Mar 2024 Direct
transaction ITI Common Stock Sale $65,897 -12,736 -6.3% $5.17 188,188 01 Mar 2024 Direct F1, F3
transaction ITI Common Stock Options Exercise $41,650 +17,500 +9.3% $2.38 205,688 04 Mar 2024 Direct
transaction ITI Common Stock Sale $67,633 -13,450 -6.5% $5.03 192,238 04 Mar 2024 Direct F1, F4
transaction ITI Common Stock Options Exercise $10,289 +4,323 +2.2% $2.38 196,561 04 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITI Stock Option (Right to Buy) Options Exercise $33,320 -14,000 -1.2% $2.38 1,136,000 29 Feb 2024 Common Stock 14,000 $2.38 Direct F5
transaction ITI Stock Option (Right to Buy) Options Exercise $44,030 -18,500 -1.6% $2.38 1,117,500 01 Mar 2024 Common Stock 18,500 $2.38 Direct F5
transaction ITI Stock Option (Right to Buy) Options Exercise $41,650 -17,500 -1.6% $2.38 1,100,000 04 Mar 2024 Common Stock 17,500 $2.38 Direct F5
transaction ITI Stock Option (Right to Buy) Options Exercise $10,289 -4,323 -0.39% $2.38 1,095,677 04 Mar 2024 Common Stock 4,323 $2.38 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As disclosed in Iteris' Form 10-Q for the quarter ended December 31, 2023, pursuant to a Rule 10b5-1 plan adopted on November 30, 2023, the Reporting Person sold only enough shares to cover the exercise price and related taxes upon the Reporting Person's exercise of a portion of his stock options that expire in September 2025. The Reporting Person retained all of the remaining shares purchased upon exercise.
F2 The reported securities were sold in multiple transactions at prices ranging from $5.11 to $5.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The reported securities were sold in multiple transactions at prices ranging from $5.06 to $5.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The reported securities were sold in multiple transactions at prices ranging from $5.00 to $5.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The option vested in full on September 22, 2019.